Form 4: NEXGEL Director Scott Robert Henry Sells 3,000 Shares Under 10b5-1 Trading Plan

Director Scott Robert Henry of NEXGEL, INC. executed a sale of 3,000 common stock shares on March 10, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 10, 2025, Scott Robert Henry, a director of NEXGEL, INC., sold 3,000 shares of common stock.
• The sale was executed under a Rule 10b5-1 trading plan.
• The shares were sold at a weighted average price of $2.8737 per share, with individual sales ranging from $2.8200 to $2.9350.
• Following the transaction, Henry directly owns 138,053 shares of NEXGEL common stock.
• The shares sold were originally purchased in the open market on September 16, 2022, and were not part of recent registered direct offerings.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily indicate a positive or negative outlook on the company.

Industry Context

Sales by insiders are a common occurrence and are often viewed in the context of pre-planned trading activities (such as Rule 10b5-1 plans) rather than a direct reflection of the company's current or future prospects.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder sentiment, but the existence of a 10b5-1 plan mitigates concerns about insider information.

Key Dates